OneVentures • 22 March 2016

$20m in financing for blood-based bowel cancer test

OneVentures

Venture capital firm OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer.

Learn More

You may also like

12 January 2021

Healthcare

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®


30 August 2017

OneVentures

Clinical Genomics hits a milestone in colon cancer prevention


18 October 2016

OneVentures

Clinical Genomics Strenghtens it’s Leadership Team with Multiple Key Appointments


18 October 2016

OneVentures

Data published in Cancer Medicine Demostrate Clinical Genomics’ Blood Test for Colorectal Cancer Recurrence is Two-Fold More Sensitive than CEA Test


View All